Carrito de compra
Su pedido cuenta con 0 productos
Envío gratis a partir de $389.00 (Consulta T&C)
| ISBN: | 9783319202730 |
|---|---|
| Formato: | Page Fidelity |
| Idioma: | Inglés |
| Editorial: | Springer Nature |
| Tema: | Medicina |
| Subtema: | Neurología |
| Año de publicación: | 2015-10-01 |
Adenosine A2A receptor antagonists have shown great promise in the treatment of Parkinsons Disease and alleviation of symptoms. This book addresses various aspects of this class of drugs from their chemical development to their clinical use. Among the many insightful chapters contained in this book, there are three unique reviews that have not previously been published in any format: (1) a history of istradefylline, the first A2A antagonist approved for treatment of Parkinsons Disease, (2) an overview of neuroimaging studies in human death and disease and (3) a study of urate as a possible biomarker and neuroprotectant.